4//SEC Filing
CHAPLIN DAVID 4
Accession 0001209191-18-039167
CIK 0000908259other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:12 PM ET
Size
5.8 KB
Accession
0001209191-18-039167
Insider Transaction Report
Form 4
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-06-20+258,171→ 258,171 totalExercise: $0.22Exp: 2024-06-20→ Common Stock (258,171 underlying)
Footnotes (2)
- [F1]Dr. Chaplin was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per shares (the "Stock Options"), in connection with his service as a member of the Board of Directors pursuant to the Amended and Restated Mateon Therapeutics, Inc. 2015 Equity Incentive Plan and the Amended and Restated Non-Employee Director Compensation Policy.
- [F2]The Stock Options will vest in full on June 20, 2019, subject to Dr. Chaplin's continued service on the Board of Directors as of such date.
Documents
Issuer
MATEON THERAPEUTICS INC
CIK 0000908259
Entity typeother
Related Parties
1- filerCIK 0001167232
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:12 PM ET
- Size
- 5.8 KB